Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Cited In for PubMed (Select 12525292)

1.

Cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy: long-term follow up.

Araújo EF, Chamlian EG, Peroni AP, Pereira WL, Gandra SM, Rivetti LA.

Rev Bras Cir Cardiovasc. 2014 Jan-Mar;29(1):31-6. English, Portuguese.

2.

Genetic susceptibility to Chagas disease: an overview about the infection and about the association between disease and the immune response genes.

Ayo CM, Dalalio MM, Visentainer JE, Reis PG, Sippert EÂ, Jarduli LR, Alves HV, Sell AM.

Biomed Res Int. 2013;2013:284729. doi: 10.1155/2013/284729. Epub 2013 Aug 28. Review.

3.

Prevalence of antibody to Trypanosoma cruzi in Hispanic-surnamed patients seen at Parkland Health & Hospital System, Dallas, Texas.

Arena R, Mathews CE, Kim AY, Lenz TE, Southern PM.

BMC Res Notes. 2011 Apr 29;4:132. doi: 10.1186/1756-0500-4-132.

4.

Genotoxicity revaluation of three commercial nitroheterocyclic drugs: nifurtimox, benznidazole, and metronidazole.

Buschini A, Ferrarini L, Franzoni S, Galati S, Lazzaretti M, Mussi F, Northfleet de Albuquerque C, Maria Araújo Domingues Zucchi T, Poli P.

J Parasitol Res. 2009;2009:463575. doi: 10.1155/2009/463575. Epub 2009 Oct 21.

5.

New perspectives of infections in cardiovascular disease.

Fong IW.

Curr Cardiol Rev. 2009 May;5(2):87-104. doi: 10.2174/157340309788166679.

6.

A 9,000-year record of Chagas' disease.

Aufderheide AC, Salo W, Madden M, Streitz J, Buikstra J, Guhl F, Arriaza B, Renier C, Wittmers LE Jr, Fornaciari G, Allison M.

Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2034-9. Epub 2004 Feb 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk